What are key considerations in managing head and neck cancer–related dysphagia?

• A. Baseline swallow function is unaffected by treatment.
• B. Treatment timing does not influence therapy.
• C. Texture and pacing of intake are fixed and unchanging.
• D. Baseline and post-treatment swallow function, mucosal health, fibrosis risk, texture and pacing of intake, timing of therapy, and coordination with oncology to minimize adverse effects.

Answer: (D)

Key considerations in head and neck cancer–related dysphagia revolve around how treatment will impact swallowing and how care can adapt to protect safety and nutrition. This means establishing how the patient swallows before treatment and tracking changes after therapy to guide rehabilitation and dietary choices. Mucosal health matters because radiation and chemotherapy can cause mucositis, edema, and pain that make swallowing painful and slower, increasing the risk of choking or aspiration if not managed. Fibrosis risk is another critical factor; radiation can stiffen swallowing muscles and limit airway protection and esophageal opening, so therapy plans often include targeted exercises and compensatory strategies to counteract these changes. The texture and pacing of intake must be tailored to the individual’s current swallow capacity, balancing safety with adequate nutrition, rather than using fixed diets. The timing of therapy is important as well—earlier swallow rehabilitation, sometimes even before or early during treatment, can improve long-term outcomes and help maintain function. Finally, coordinating with the oncology team ensures rehab strategies align with cancer treatment, minimize adverse effects, and optimize overall care.